{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:20:16Z","timestamp":1790104816857,"version":"4.0.1"},"reference-count":62,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SERB","award":["EEQ\/2016\/000318"],"award-info":[{"award-number":["EEQ\/2016\/000318"]}]},{"name":"CSIR","award":["EEQ\/2016\/000318"],"award-info":[{"award-number":["EEQ\/2016\/000318"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: AML is a heterogeneous hematological malignancy distinguished by the clonal expansion of immature myeloid progenitor cells. Despite advances in therapy, relapse rates remain high, and outcomes are poor. The WT1 gene has emerged as a potential contributor to leukemogenesis, but its clinical relevance at the transcriptional level is not fully understood. This study employed RNA sequencing as a discovery tool to identify WT1 gene expression in AML and further investigated its role in diagnosis, prognosis, and treatment response. Methods: Between 2020 and 2024, 345 diagnostic, 259 post-induction, and 70 relapse-stage BM or PB samples were prospectively collected from de novo AML patients at AIIMS, New Delhi. RNA sequencing was initially performed on five paired diagnosis-relapse samples to profile transcriptomic changes and assess WT1 expression dynamics. WT1 expression was further validated by qPCR. The relationship between WT1 expression and various clinical parameters was evaluated using Cox regression analysis to determine its impact on prognosis. Results: RNA sequencing and qPCR confirmed WT1 overexpression at diagnosis, which significantly declined following induction therapy. High WT1 expression at diagnosis was linked with adverse clinical characteristics, including elevated WBC counts and higher blast percentages and predicted poor survival outcomes. WT1 expression was identified as a significant prognostic marker, correlating with OS and EFS. Conclusions: By integrating RNA sequencing with targeted validation, this study highlights WT1 expression as a critical biomarker for AML diagnosis, prognosis, and treatment response. The findings suggest that WT1 expression may serve as a valuable tool for monitoring disease status, risk stratification, and guiding treatment decisions in AML, with potential applications for WT1-targeted precision therapies.<\/jats:p>","DOI":"10.3390\/cancers17111818","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:47:34Z","timestamp":1748512054000},"page":"1818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-7343","authenticated-orcid":false,"given":"Harsh","family":"Goel","sequence":"first","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3014-4913","authenticated-orcid":false,"given":"Avanish Kumar","family":"Pandey","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somorjit Singh","family":"Ningombam","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat","family":"Naz","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshita","family":"Makkar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Singh","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-1456","authenticated-orcid":false,"given":"Shadab","family":"Ali","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-8702","authenticated-orcid":false,"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Prasad","family":"Meena","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Kumar","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Hematology, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4130-724X","authenticated-orcid":false,"given":"Ranjit Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-8408","authenticated-orcid":false,"given":"Atul","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goura Kishor","family":"Rath","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Showket","family":"Hussain","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Institute of Cancer Prevention & Research, Noida 201301, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu Kumar","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Bioengineering, Galgotias University, Greater Noida 203201, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-976X","authenticated-orcid":false,"given":"Pranay","family":"Tanwar","sequence":"additional","affiliation":[{"name":"Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: Epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"ref_2","first-page":"151","article-title":"Molecular update on biology of Wilms Tumor 1 gene and its applications in acute myeloid leukemia","volume":"10","author":"Goel","year":"2020","journal-title":"Am. J. Blood Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-Related Myeloid Neoplasms: When Genetics and Environment Collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","first-page":"472","article-title":"Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia","volume":"11","author":"Goel","year":"2021","journal-title":"Am. J. Blood Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1200\/JCO.2017.72.6745","article-title":"Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia","volume":"35","author":"Leonard","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Itzykson","year":"2014","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.1991.tb04444.x","article-title":"Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)","volume":"78","author":"Bennett","year":"1991","journal-title":"Br. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5858\/2010-0387-RAR.1","article-title":"Multiparameter flow cytometry in the diagnosis and management of acute leukemia","volume":"135","author":"Peters","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.5858\/2010-0245-RA.1","article-title":"Acute myeloid leukemia diagnosis in the 21st century","volume":"134","author":"Betz","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Estey","year":"2017","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2008.04.008","article-title":"Epigenetics in acute myeloid leukemia","volume":"35","author":"Plass","year":"2008","journal-title":"Semin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminhematol.2008.09.008","article-title":"Epigenetics of acute lymphocytic leukemia","volume":"46","author":"Yang","year":"2009","journal-title":"Semin. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2009.12.001","article-title":"Leukemia stem cells","volume":"20","author":"Lane","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2016-10-696039","article-title":"Therapeutic targeting of acute myeloid leukemia stem cells","volume":"129","author":"Pollyea","year":"2017","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in Acute Myeloid Leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/cncr.33458","article-title":"De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017","volume":"127","author":"Sasaki","year":"2021","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOH.0000000000000018","article-title":"New strategies for relapsed acute myeloid leukemia: Fertile ground for translational research","volume":"21","author":"Dinner","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_21","first-page":"147","article-title":"Optimal Post-Remission Consolidation Therapy in Patients with AML","volume":"147","author":"Dillon","year":"2023","journal-title":"Acta Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.gde.2005.08.004","article-title":"Transcriptional regulation by WT1 in development","volume":"15","author":"Roberts","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molcel.2010.01.010","article-title":"WT1 the oncogene: A tale of death and HtrA","volume":"37","author":"Essafi","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Belluti, S., Rigillo, G., and Imbriano, C. (2020). Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates. Cells, 9.","DOI":"10.3390\/cells9030760"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2141.2002.03261.x","article-title":"Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms\u2019 tumour gene WT1 at levels similar to those in leukaemia cells","volume":"116","author":"Hosen","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1093\/nar\/gkx1274","article-title":"Role for first zinc finger of WT1 in DNA sequence specificity: Denys\u2013Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1242\/dev.153163","article-title":"Wilms\u2019 tumour 1 (WT1) in development, homeostasis and disease","volume":"144","author":"Hastie","year":"2017","journal-title":"Development"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1654597","article-title":"Transcriptional repression mediated by the WT1 Wilms tumor gene product","volume":"253","author":"Madden","year":"1991","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45255","DOI":"10.1038\/srep45255","article-title":"WT1 expression in breast cancer disrupts the epithelial\/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel","volume":"7","author":"Artibani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1038\/srep08924","article-title":"Wilms\u2019 tumor 1 (WT1) expression and prognosis in solid cancer patients: A systematic review and meta-analysis","volume":"5","author":"Qi","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2018-03-837468","article-title":"Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis","volume":"132","author":"Pronier","year":"2018","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: A revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1101\/gr.079558.108","article-title":"RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays","volume":"18","author":"Marioni","year":"2008","journal-title":"Genome Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Ley, T.J., Miller, C., Ding, L., Raphael, B.J., Mungall, A.J., Robertson, A.G., Hoadley, K., Triche, T.J., and Laird, P.W. (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med., 368, 2059\u20132074.","DOI":"10.1056\/NEJMoa1301689"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1073\/pnas.88.21.9618","article-title":"Alternative splicing and genomic structure of the Wilms tumor gene WT1","volume":"88","author":"Haber","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29976","DOI":"10.1074\/jbc.270.50.29976","article-title":"The transcriptional effect of WT1 is modulated by choice of expression vector","volume":"270","author":"Reddy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_39","first-page":"415","article-title":"Products of alternatively spliced transcripts of the Wilms\u2019 tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways","volume":"10","author":"Wang","year":"1995","journal-title":"Oncogene"},{"key":"ref_40","first-page":"405","article-title":"Expression of the Wilms\u2019 tumor gene (WT1) in human leukemias","volume":"6","author":"Miwa","year":"1992","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tig.2012.04.004","article-title":"The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis","volume":"28","author":"Chau","year":"2012","journal-title":"Trends Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2009.08063.x","article-title":"WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes","volume":"149","author":"Galimberti","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/leu.2013.111","article-title":"Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML","volume":"27","author":"Hoyos","year":"2013","journal-title":"Leukemia"},{"key":"ref_45","first-page":"2138","article-title":"The expression of the Wilms\u2019 tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells","volume":"8","author":"Brieger","year":"1994","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/ejh.ejh_26_19","article-title":"Study of Wilms\u2019 tumor 1 gene expression in patients with acute myeloid leukemia","volume":"44","author":"Ahmad","year":"2019","journal-title":"Egypt. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s10238-023-00995-5","article-title":"High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk","volume":"23","author":"Xu","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","article-title":"High levels of Wilms\u2019 tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome","volume":"90","author":"Bergmann","year":"1997","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2005.03.5303","article-title":"High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia","volume":"24","author":"Lapillonne","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00432-014-1832-y","article-title":"Prognostic impact of WT1 expression prior to hematopoietic stem cell transplantation in children with malignant hematological diseases","volume":"141","author":"Woehlecke","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/sj.leu.2403809","article-title":"Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia","volume":"19","author":"Weisser","year":"2005","journal-title":"Leukemia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","article-title":"Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: A European LeukemiaNet study","volume":"27","author":"Cilloni","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_53","first-page":"926","article-title":"Prognostic implications of Wilms\u2019 tumor gene (WT1) expression in patients with de novo acute myeloid leukemia","volume":"89","author":"Cervera","year":"2004","journal-title":"Haematologica"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.34172\/apb.2021.021","article-title":"WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy","volume":"11","author":"Mehralizadeh","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1340909","DOI":"10.3389\/fonc.2024.1340909","article-title":"Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemia","volume":"14","author":"Ahmed","year":"2024","journal-title":"Front. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e27671","DOI":"10.1002\/pbc.27671","article-title":"Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values","volume":"66","author":"Zeller","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2141.2004.04952.x","article-title":"WT1 gene expression: An excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients\u2014Results from a single-centre study","volume":"125","author":"Olesen","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/bjh.12181","article-title":"Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: Predictive role of WT1 expression","volume":"160","author":"Pozzi","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20131587","article-title":"Mechanisms of transcriptional regulation by WT1 (Wilms\u2019 tumour 1)","volume":"461","author":"Toska","year":"2014","journal-title":"Biochem. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2017014175","article-title":"Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia","volume":"2","author":"Maslak","year":"2018","journal-title":"Blood Adv."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Raguraman, P., Balachandran, A.A., Chen, S., Diermeier, S.D., and Veedu, R.N. (2021). Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers, 13.","DOI":"10.3390\/cancers13215555"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"787108","DOI":"10.3389\/fonc.2022.787108","article-title":"Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges","volume":"12","author":"Kang","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:43:08Z","timestamp":1760031788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cancers17111818"],"URL":"https:\/\/doi.org\/10.3390\/cancers17111818","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}